Nanomedicine News

RSS

Sorrento to Present Data on Cynviloq Nanoparticle Paclitaxel for Ovarian Cancer at AACR Conference

Sorrento Therapeutics, Inc. announced today it will present the clinical data for Cynviloq™ (IG-001), which resulted in its approval as 1st line treatment of ovarian cancer by Korean FDA in March of 2013.

17 Sep 2013

NanoBio to Present New Safety Data of Nanoemulsion Adjuvanted Intramuscular Vaccine for RSV Prevention

NanoBio Corporation today announced that the company will present new data at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting showing the safety and efficacy of a nanoemulsion (NE) adjuvanted intramuscular vaccine for the prevention of respiratory syncytial virus (RSV).

From BlueWillow Biologics 12 Sep 2013

Nanoparticle-Delivered miR-200 Reduces Cancer Burden and Inhibits Metastasis

A family of microRNAs (miR-200) blocks cancer progression and metastasis by stifling a tumor’s ability to weave new blood vessels to support itself, researchers at The University of Texas MD Anderson Cancer Center report today in Nature Communications.

12 Sep 2013

Novavax Reports Positive Findings from RSV F Nanoparticle Vaccine Studies at 53rd ICAAC

Novavax, Inc. a clinical-stage biopharmaceutical company creating novel recombinant nanoparticle vaccines and vaccine adjuvants, today reported positive findings from recent clinical and preclinical studies of its respiratory syncytial virus F-protein (RSV F) nanoparticle vaccine candidate in poster sessions at the 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Denver, Colorado.

From Novavax Inc. 12 Sep 2013

Veritas Bio Granted European Patent for RNA Delivery

Veritas Bio, LLC, a privately held biotechnology company is pleased to announce that the European Patent Office (EPO) has granted a patent to Veritas for European Patent Application No. 07 873 598.2 1401. The patent relates to the “In vivo Delivery of Nucleic Acids.”

11 Sep 2013

Translational Data on Cerulean’s CRLX101 Polymeric Nanoparticle Candidate Published in PNAS

Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced the publication of translational data on the company's lead candidate, CRLX101, currently in Phase 2 trials. The study results, which are published in PNAS, indicate that animal pharmacokinetic and pharmacodynamic data are translatable to humans.

From Cerulean Pharma 11 Sep 2013

Superparamagnetic Iron Oxide Nanoparticles May Help Improve Assessment of Heart Attack Risk

A Binghamton University researcher hopes to give doctors a more accurate way of determining a patient’s risk of heart attack or stroke.

11 Sep 2013

New BIONOVA NANO SKIN TECH Solution for Dry Foot and Foot Inflammation

When it comes to beauty care, feet are not the first area to come to mind. The feet experience the most daily stress of wear and tear yet we often forget they need proper care, as well. Dry skin on the feet is the culprit of cracked heels, flakiness, itchiness and a burning sensation, which brings disruptive discomfort for a body area that is always in use.

10 Sep 2013

DNA Nanoparticles Reveal Critical Role of Protein STING

A little STING could go a long way in helping treat or even avoid autoimmune diseases such as arthritis, type 1 diabetes and multiple sclerosis, researchers report.

10 Sep 2013

Nanodiamonds Enable Direct Application of Chemotherapy to Brain Tumors

Researchers at UCLA’s Jonsson Comprehensive Cancer Center have developed a new drug delivery system using nanodiamonds (NDs) that allows for direct application of chemotherapy to brain tumors with fewer harmful side effects and better cancer-killing efficiency than existing treatments.

From University of California, Los Angeles 10 Sep 2013

Nanomedicine News

Sorrento to Present Data on Cynviloq Nanoparticle Paclitaxel for Ovarian Cancer at AACR Conference

NanoBio to Present New Safety Data of Nanoemulsion Adjuvanted Intramuscular Vaccine for RSV Prevention

Nanoparticle-Delivered miR-200 Reduces Cancer Burden and Inhibits Metastasis

Novavax Reports Positive Findings from RSV F Nanoparticle Vaccine Studies at 53rd ICAAC

Veritas Bio Granted European Patent for RNA Delivery

Translational Data on Cerulean’s CRLX101 Polymeric Nanoparticle Candidate Published in PNAS

Superparamagnetic Iron Oxide Nanoparticles May Help Improve Assessment of Heart Attack Risk

New BIONOVA NANO SKIN TECH Solution for Dry Foot and Foot Inflammation

DNA Nanoparticles Reveal Critical Role of Protein STING

Nanodiamonds Enable Direct Application of Chemotherapy to Brain Tumors

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Sustainable Future for Carbon Nanotubes

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Enhancing Material Properties through Nanotube Encapsulation

Modeling the Growth of Hexagonal Boron Nitride for Next-Generation Applications

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials